Drugmaker Gilead said it will allow cheap, generic versions to be sold in 120 poor countries with high HIV rates, mostly in ...

While the rollout of highly active antiretroviral therapy (HAART) has transformed HIV from a fatal illness into a largely ...

Health experts say lenacapavir could reduce the number of global HIV infections significantly. But it needs to be cheaper to be effective.When lenacapavir test results were presented at a World AIDS ...

A new drug called Lenacapavir is nearly 100% effective in preventing and treating HIV infections. But will it be made affordable for the tens of millions of people around the world who need it?

"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

Gilead Sciences has announced the outcomes from the Phase III PURPOSE 2 trial evaluating lenacapavir for HIV prevention.

According to a study published in the New England Journal of Medicine, twice-yearly injection of Lenacapavir offers a 96 percent ...

Cabenuva is a two-monthly injection administered in the buttock. Lenacapavir, a six-monthly injection under the skin, is ...

A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published ...

An update from the PURPOSE 2 trial focused on adherence and pharmacokinetics data for lenacapavir, used to prevent HIV.

Following the promising multicentre, international Purpose 1 and Purpose 2 clinical trials with lenacapavir for HIV ...

Discover the groundbreaking results of Lenacapavir, a twice-yearly injection that reduces HIV infection risk offering an ...